EP2796457
Genz 112638 til meðhöndlunar á Gauchers- eða Fabrys-sjúkdómi í samsettri meðferð
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
24.11.2010EP published:
18.5.2016EP application number:
14164650.5
EP translation filed:
10.8.2016Grant published:
15.9.2016EPO information:
European Patent Register
Max expiry date:
23.11.2030Expiry date:
23.11.2020
Title:
GENZ 112638 FOR TREATING GAUCHER OR FABRY DISEASE IN COMBINATION THERAPY
Timeline
Today
24.11.2010EP application
18.5.2016EP Publication
10.8.2016Translation submitted
15.9.2016Registration published
23.11.2020Expires
Owner
Name:
Genzyme CorporationAddress:
500 Kendall Street, 02142, Cambridge, MA, US
Inventor
Name:
Liu, HanlanAddress:
Lexington, MA, US
Name:
Willis, ChrisAddress:
Southborough, MA, US
Name:
Bhardwaj, RenuAddress:
Ashland, MA, US
Name:
Copeland, Diane, P.Address:
Billerica, MA, US
Name:
Harianawala, AbizerAddress:
Acton, MA, US
Name:
Skell, JeffreyAddress:
Westborough, MA, US
Name:
Marshall, JohnAddress:
Hopedale, MA, US
Name:
Kochling, JianmeiAddress:
Wellesley, MA, US
Name:
Palace, GerardAddress:
Framingham, MA, US
Name:
Peterschmitt, JudithAddress:
Watertown, MA, US
Name:
Siegel, CraigAddress:
Woburn, MA, US
Name:
Cheng, SengAddress:
Natick, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
264748 PDate:
27.11.2009Country:
US
Classification
Categories:
C07D 405/06, A61K 31/4025, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 13.10.2016
Expires: 23.11.2017
Payer: Árnason Faktor
Number: 8
Paid: 5.10.2017
Expires: 23.11.2018
Payer: Árnason Faktor
Number: 9
Paid: 5.10.2018
Expires: 23.11.2019
Payer: Árnason Faktor
Number: 10
Paid: 8.10.2019
Expires: 23.11.2020
Payer: Árnason Faktor